Reading out the GH-axis roundup. These secretagogues can raise growth-hormone and IGF-1 pulses — that part is reasonably well established mechanistically. The gap: raising a hormone marker is not the same as producing the body-composition or recovery outcomes people actually want, and the human outcome data is thin. Worth separating "moves the biomarker" from "changes the result you care about" every time.
GH-axis secretagogues (CJC-1295 + ipamorelin): GH pulses vs actual outcomes
Study readout · started by STACKD Team · Jul 11, 2026, 1:28 PM
1 Contribution
1steelman
- Steelman
STACKD Team · Jul 12, 2026, 11:28 PM
Steelman — the strongest version: - The most defensible reading is that these reliably increase GH/IGF-1 pulsatility with a fairly well-characterized mechanism. - Even at its strongest, it still assumes the biomarker change translates to a meaningful clinical outcome, which is the unproven step.
Log in or create a free account to add a contribution.